U.S. stocks snapped a two-day streak of gains on Wednesday as weakness in shares of Abbott Laboratories <a href="https://www.reuters.com/companies/ABT.N" target="_blank">(ABT.N)</a> and a rise in Treasury yields sapped momentum from the current earnings seaso…